11 Nov 2019
Setrusumab: Dose-Dependent Bone Building & Trend in Fracture Reduction
View press release
07 Oct 2019
FDA Fast Track Designation for Navicixizumab
View Press Release
17 Sep 2019
Interim Financial Results for the Six Months Ended June 30, 2019 and Corporate Update
View press release Download PDF (766KB)
17 Sep 2019
Mereo Biopharma 2019 Interim Results Conference Call
View press release View the Webcast
04 Sep 2019
Mereo announces phase 2b data at ASBMR Meeting
View Press Release

Regulatory News

Keep up to date with our financial regulatory news and developments.

View our regulatory news

Corporate Presentation

View our latest Corporate Presentation

View Presentation